Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2 | NEJM - nejm.org

Correspondence from The New England Journal of Medicine — Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

The omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for coronavirus disease 2019 (Covid-19), has spread rapidly around the world and … [+7467 chars]

full article...